Cargando…

Immunotherapy for Merkel cell carcinoma: a turning point in patient care

Merkel Cell carcinoma (MCC) is a rare but aggressive cancer, with an estimated disease-associated mortality as high as 46%. MCC has proven to be an immunologically responsive disease and the advent of immune checkpoint inhibitors has changed the treatment landscape for patients with advanced MCC. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Isaac S., Bhatia, Shailender, Kaufman, Howard L., Lipson, Evan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865292/ https://www.ncbi.nlm.nih.gov/pubmed/29566749 http://dx.doi.org/10.1186/s40425-018-0335-9

Ejemplares similares

Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series
por: LoPiccolo, Jaclyn, et al.
Publicado: (2019)

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
por: Kaufman, Howard L., et al.
Publicado: (2018)

Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy
por: Miller, Natalie J., et al.
Publicado: (2018)

Merkel Cell Carcinoma: An Update and Immunotherapy
por: Uchi, Hiroshi
Publicado: (2018)

Complete resolution of PD-1 refractory, locoregionally advanced Merkel cell carcinoma with talimogene laherparepvec
por: Singh, Neha, et al.
Publicado: (2023)

How we treat Merkel cell carcinoma: within and beyond current guidelines
por: Park, Song Y, et al.
Publicado: (2021)

Immunotherapy in Merkel cell carcinoma: role of Avelumab
por: Palla, Amruth R, et al.
Publicado: (2018)

Predictors of immunotherapy benefit in Merkel cell carcinoma
por: Kacew, Alec J., et al.
Publicado: (2020)

Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?
por: Tanda, Enrica Teresa, et al.
Publicado: (2021)

Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 Patients
por: Tarabadkar, Erica S., et al.
Publicado: (2018)

Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma
por: Iyer, Jayasri G., et al.
Publicado: (2016)

An Updated Review of the Biomarkers of Response to Immune Checkpoint Inhibitors in Merkel Cell Carcinoma: Merkel Cell Carcinoma and Immunotherapy
por: Fojnica, Adnan, et al.
Publicado: (2023)

Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma
por: Iyer, Jayasri G, et al.
Publicado: (2015)

Outcome of patient with myasthenia gravis with the use of immunotherapy in metastatic Merkel cell carcinoma
por: Williams, Sarah, et al.
Publicado: (2022)

Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review
por: Akaike, Tomoko, et al.
Publicado: (2022)

Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck
por: Cook, Maclean M., et al.
Publicado: (2020)

Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study
por: Bhatia, Shailender, et al.
Publicado: (2022)

Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
por: D'Angelo, Sandra P, et al.
Publicado: (2020)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma
por: Pietropaolo, Valeria, et al.
Publicado: (2020)

Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance
por: Lewis, Christopher W., et al.
Publicado: (2019)

Systemic immune suppression as a stage-independent predictor of diminished Merkel cell carcinoma-specific survival
por: Paulson, Kelly G., et al.
Publicado: (2012)

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma
por: D’Angelo, Sandra P., et al.
Publicado: (2019)

Merkel Cell Polyomavirus Strains in Patients with Merkel Cell Carcinoma
por: Touzé, Antoine, et al.
Publicado: (2009)

Merkel cell polyomavirus in Merkel cell carcinoma of Italian patients
por: Paolini, Francesca, et al.
Publicado: (2011)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma, France
por: Foulongne, Vincent, et al.
Publicado: (2008)

Merkel cell polyomavirus and cutaneous Merkel cell carcinoma
por: Minutilli, Ettore, et al.
Publicado: (2016)

Merkel cell polyomavirus and associated Merkel cell carcinoma
por: Yang, June F., et al.
Publicado: (2021)

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma
por: Nghiem, Paul, et al.
Publicado: (2021)

COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy
por: da Costa, Cesar Martins, et al.
Publicado: (2020)

Merkel Cell Carcinoma: An Otolaryngological Point of View of An Unusual Sinonasal Mass
por: De Sousa Machado, André, et al.
Publicado: (2022)

Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma
por: Tachiki, Lisa May Ling, et al.
Publicado: (2023)

Living with Merkel Cell Carcinoma (MCC): Development of a Conceptual Model of MCC Based on Patient Experiences
por: Kaufman, Howard L., et al.
Publicado: (2018)

Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma
por: Lauttia, S, et al.
Publicado: (2014)

Epidemiology of Merkel Cell Polyomavirus Infection and Merkel Cell Carcinoma
por: Silling, Steffi, et al.
Publicado: (2022)

Merkel cell carcinoma
por: Koljonen, Virve
Publicado: (2006)

Merkel Cell Carcinoma
por: Dellambra, Elena, et al.
Publicado: (2021)

Merkel cell carcinoma
por: Mistry, K., et al.
Publicado: (2021)

Successful immunotherapy and irradiation in a HIV-positive patient with metastatic Merkel cell carcinoma
por: Linge, Annett, et al.
Publicado: (2018)

Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma
por: Nghiem, Paul, et al.
Publicado: (2017)

Merkel Cell Polyomavirus Is Frequently Detected in Korean Patients with Merkel Cell Carcinoma
por: Chun, Seung Min, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7qqotj9r356vru6brdqv140vm4